AI use in breast radiology increased cancer detection without higher recall rates, according to a 100,000+ case multicenter study.
Key Details
- 1Study conducted across four sites and included nine experienced breast radiologists.
- 2Over 100,000 digital breast tomosynthesis (DBT) exams analyzed.
- 3Results compared pre- and post-AI implementation: 54,000 exams before AI (339 true positives) vs. nearly 49,000 with AI (369 true positives).
- 4AI improved invasive and dense breast cancer detection and lowered average diagnosis stage.
- 5No increase in recall rates was observed with AI usage.
- 6The AI tool was provided by iCAD and the DBT system by GE HealthCare.
Why It Matters
Demonstrates AI's practical benefits in increasing breast cancer detection while maintaining recall rates, addressing workload and burnout concerns. This adds impactful real-world data supporting AI adoption in radiology practices.
Source
Radiology Business
Related News
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
UCLA Review Evaluates Breast AI for Early Cancer Detection
A UCLA-led review analyzes current evidence for AI tools in screening mammography, focusing on their capability to detect interval cancers.
•Radiology Business
Vara's AI Gains World's First Approval for Radiologist-Free Mammogram Triage
Vara has secured the world's first regulatory approval for an AI tool that autonomously classifies certain mammograms as normal, bypassing radiologist review.